Overview

Clinical Value of Sequential Gefitinib With Pemetrexed/Platinum for Advanced NSCLC

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The aim of this study is to explore the Clinical Value of Sequential Gefitinib With Pemetrexed/Platinum compare with Pemetrexed/Platinum for Advanced NSCLC.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Fudan University
Treatments:
Gefitinib
Pemetrexed